ArticleCadernos de saude publica2025
National and subnational plans for primary prevention and early detection of oral and oropharyngeal cancer: a scoping review.
Article in Cadernos de saude publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Effectiveness of Organized Strategies to Enhance Access to Preventive Oral Cancer Screening Among High-Risk Individuals in Brazil: A Randomized Clinical Trial in Primary Care.International journal of cancer · 2026Trial
- Advancing Non-Invasive Diagnosis of Oral Epithelial Dysplasia: Comparative Insights from In Vivo Optical Coherence Tomography and Histopathology.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This scoping review maps primary prevention and early detection strategies for oral and oropharyngeal cancer across national cancer plans and noncommunicable disease plans from all World Health Organization Member States. Following PRISMA-ScR guidelines, bibliographic search was performed on key organization websites until March 2023. Of the 194 countries assessed three had subnational plans, resulting in 264 self-governing political entities and similar with revised plans. Among these, 124 (47%) addressed oral and oropharyngeal cancer risk factors and preventive strategies, including 73 national and 51 subnational plans (one from Australia, two from the United Kingdom and 48 from the United States) across 76 (39.2%) countries. Southeast Asia led with 81.8% self-governing political entities mentioning oral and oropharyngeal cancer risk factors and preventive strategies, followed by the Americas (63.5%). Western Pacific and Eastern Mediterranean regions had the lowest coverage with 24.2% and 23.8%, respectively. Tobacco use was the most discussed oral and oropharyngeal cancer risk factor in primary prevention plans (63.7%), followed by HPV infection (54%) and alcohol consumption (35.5%). Opportunistic examination was the most common strategy for early detection, recommended by 29% of self-governing political entities, followed by screening in high-risk individuals (14.5%), self-examination (5.6%), and population-based screening (2.4%). Despite the high oral and oropharyngeal cancer incidence in many countries, most cancer plans only indirectly covered it and showed a great diversity of preventive strategies. Missing data in available documents should not imply an absence of an oral and oropharyngeal cancer policy. Other documents may exist but were not available on the websites, highlighting potential bias.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.